Bank Of Cyprus Oncology Center
- Address
- lock Available on a paid plan
Neoplasms and Medical Oncology research
At the Bank Of Cyprus Oncology Center in Strovolos, Cyprus, clinical trials focus on cancer care across several neoplastic diseases, with an emphasis on improving treatment outcomes, disease control, and supportive care for patients.
- Breast cancer, especially ER positive HER2 negative breast cancer, is being studied to see whether new endocrine-based approaches can better delay metastasis and improve long-term outcomes.
- High-risk retroperitoneal sarcoma, including leiomyosarcoma and liposarcoma, is under investigation to determine whether adding treatment before surgery can improve prognosis.
- Solid tumors are included in research evaluating the safety and tolerability of newer immunotherapy combinations.
- Supportive care studies are also exploring ways to reduce endocrine therapy-related pain and improve quality of life for people living with early breast cancer.
Overall, the site’s trial portfolio combines efforts to test new cancer therapies, refine treatment effectiveness, and improve symptom management for patients receiving oncology care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 4 other sites in Cyprus
Therapeutic Area Benchmark — Cyprus
Select a therapeutic area to compare against other sites in Cyprus.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Cyprus
Market Share
Country: Cyprus
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Bank Of Cyprus Oncology Center
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| EORTC 2129-BCG: Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse (TREAT ctDNA) | Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer European Organi | Phase III | Recruiting | Feb 2024 | — |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amiloride Hydrochloride | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.